437 related articles for article (PubMed ID: 29024109)
1. Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction.
Sehested TSG; Gerds TA; Fosbøl EL; Hansen PW; Charlot MG; Carlson N; Hlatky MA; Torp-Pedersen C; Gislason GH
J Intern Med; 2018 Mar; 283(3):268-281. PubMed ID: 29024109
[TBL] [Abstract][Full Text] [Related]
2. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
Landi SN; Sandler RS; Pate V; Lund JL
Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitor use represents an independent risk factor for myocardial infarction.
Shih CJ; Chen YT; Ou SM; Li SY; Chen TJ; Wang SJ
Int J Cardiol; 2014 Nov; 177(1):292-7. PubMed ID: 25499395
[TBL] [Abstract][Full Text] [Related]
4. Reduced risk of gastrointestinal bleeding associated with proton pump inhibitor therapy in patients treated with dual antiplatelet therapy after myocardial infarction.
Sehested TSG; Carlson N; Hansen PW; Gerds TA; Charlot MG; Torp-Pedersen C; Køber L; Gislason GH; Hlatky MA; Fosbøl EL
Eur Heart J; 2019 Jun; 40(24):1963-1970. PubMed ID: 30851041
[TBL] [Abstract][Full Text] [Related]
5. Proton Pump Inhibitor Use and the Risk of Cardiovascular Complications and Death in Older Adults with Diabetes: A Population-Based Cohort Study.
Foresta A; Fernandez LO; Torrigiani G; Schena S; Roncaglioni MC; Nobili A; Tettamanti M; Franchi C; Fortino I; Succurro E; Sesti G; Baviera M
Drugs Aging; 2024 Mar; 41(3):239-249. PubMed ID: 38367169
[TBL] [Abstract][Full Text] [Related]
6. Clinical events as a function of proton pump inhibitor use, clopidogrel use, and cytochrome P450 2C19 genotype in a large nationwide cohort of acute myocardial infarction: results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) registry.
Simon T; Steg PG; Gilard M; Blanchard D; Bonello L; Hanssen M; Lardoux H; Coste P; Lefèvre T; Drouet E; Mulak G; Bataille V; Ferrières J; Verstuyft C; Danchin N
Circulation; 2011 Feb; 123(5):474-82. PubMed ID: 21262992
[TBL] [Abstract][Full Text] [Related]
7. No Significant Association Between Proton Pump Inhibitor Use and Risk of Stroke After Adjustment for Lifestyle Factors and Indication.
Nguyen LH; Lochhead P; Joshi AD; Cao Y; Ma W; Khalili H; Rimm EB; Rexrode KM; Chan AT
Gastroenterology; 2018 Apr; 154(5):1290-1297.e1. PubMed ID: 29269313
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors and risk for recurrent ischemic events or death in outpatients with symptomatic artery disease.
Muñoz-Torrero JFS; Zamorano J; Rico-Martín S; Rivas MD; Bacaicoa MA; Robles R; Sanchez-Bacaicoa C; Monreal M;
Atherosclerosis; 2020 Jan; 292():84-89. PubMed ID: 31785493
[TBL] [Abstract][Full Text] [Related]
9. Cerebrovascular Outcomes With Proton Pump Inhibitors and Thienopyridines: A Systematic Review and Meta-Analysis.
Malhotra K; Katsanos AH; Bilal M; Ishfaq MF; Goyal N; Tsivgoulis G
Stroke; 2018 Feb; 49(2):312-318. PubMed ID: 29339434
[TBL] [Abstract][Full Text] [Related]
10. Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.
Wang YF; Chen YT; Luo JC; Chen TJ; Wu JC; Wang SJ
Am J Gastroenterol; 2017 Jul; 112(7):1084-1093. PubMed ID: 28397874
[TBL] [Abstract][Full Text] [Related]
11. The long-term risk for myocardial infarction or stroke after proton pump inhibitor therapy (2008-2018).
Nolde M; Ahn N; Dreischulte T; Rückert-Eheberg IM; Güntner F; Günter A; Gerlach R; Tauscher M; Amann U; Linseisen J; Meisinger C; Baumeister SE
Aliment Pharmacol Ther; 2021 Oct; 54(8):1033-1040. PubMed ID: 34476821
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Risk of Stroke in Myocardial Infarction Survivors: Thirty-Year Population-Based Cohort Study.
Sundbøll J; Horváth-Puhó E; Schmidt M; Pedersen L; Henderson VW; Bøtker HE; Sørensen HT
Stroke; 2016 Jul; 47(7):1727-33. PubMed ID: 27301935
[TBL] [Abstract][Full Text] [Related]
13. Concomitant Use of Proton Pump Inhibitors and Clopidogrel Is Not Associated with Adverse Outcomes after Ischemic Stroke in Chinese Population.
Yi X; Zhou Q; Wang C; Lin J; Cheng W; Chi L
J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2859-2867. PubMed ID: 27546731
[TBL] [Abstract][Full Text] [Related]
14. Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide study.
Schjerning Olsen AM; Lindhardsen J; Gislason GH; McGettigan P; Hlatky MA; Fosbøl E; Køber L; Torp-Pedersen C; Lamberts M
BMJ; 2015 Oct; 351():h5096. PubMed ID: 26481405
[TBL] [Abstract][Full Text] [Related]
15. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
[TBL] [Abstract][Full Text] [Related]
16. Proton Pump Inhibitor Use and Risks of Cardiovascular Disease and Mortality in Patients With Type 2 Diabetes.
Geng T; Chen JX; Zhou YF; Lu Q; Wan Z; Liu L; Pan A; Liu G
J Clin Endocrinol Metab; 2023 May; 108(6):e216-e222. PubMed ID: 36573284
[TBL] [Abstract][Full Text] [Related]
17. Effect of baseline gastrointestinal risk and use of proton pump inhibitors on frequency of discontinuation of aspirin for secondary cardiovascular prevention in United kingdom primary care.
Martín Merino E; Johansson S; Nagy P; García Rodríguez LA
Am J Cardiol; 2013 Oct; 112(8):1075-82. PubMed ID: 23831164
[TBL] [Abstract][Full Text] [Related]
18. Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study.
Jackson LR; Peterson ED; McCoy LA; Ju C; Zettler M; Baker BA; Messenger JC; Faries DE; Effron MB; Cohen DJ; Wang TY
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792656
[TBL] [Abstract][Full Text] [Related]
19. Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.
Chandrasekhar J; Bansilal S; Baber U; Sartori S; Aquino M; Farhan S; Vogel B; Faggioni M; Giustino G; Ariti C; Colombo A; Chieffo A; Kini A; Saporito R; Michael Gibson C; Witzenbichler B; Cohen D; Moliterno D; Stuckey T; Henry T; Pocock S; Dangas G; Gabriel Steg P; Mehran R
Catheter Cardiovasc Interv; 2017 Jun; 89(7):E217-E225. PubMed ID: 27650638
[TBL] [Abstract][Full Text] [Related]
20. Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study.
Subherwal S; Patel MR; Kober L; Peterson ED; Bhatt DL; Gislason GH; Olsen AM; Jones WS; Torp-Pedersen C; Fosbol EL
Eur J Prev Cardiol; 2015 Mar; 22(3):317-25. PubMed ID: 24398369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]